Safety and efficacy comparision of the teneligliptin verses metformin in type-ii diabetes mellitus

In Our Study Safety and Efficacy Comparison of The Teneligliptin Verses Metformin Type-II Diabetes Mellitus, States that we are taking a total 120 patients were included in our study by the section criteria, both males and females, males are higher majority Population diagnosed by the Type-II DM. A prospective –observational study was conducted at Siddhartha Hospital, Kakinada for a period of six months study was carried out for a period of 6 months January 2018 to July 2018. In the process of case collection we are collecting to the blood samples for the all patients, In addition to effective glycemic control results that suggested teneligliptin is well tolerated in type –II diabetes mellitus along with triglycerides monitoring And of all the above glycemic and non glycemic parameters reports there are no major adverse effects when using of teneligliptin which gives a suitable approach towards the management of type -II DM safely and effectively. The data was analysed by applying the Microsoft Excel 2013 (Microsoft Corporation) And Student Graph Pad Prism. Teneligliptin may show benefits with hypoglycaemia and had chances of increase in triglycerides, monitoring of triglycerides along with teneligliptin therapy is more safe and effective. Using of Teneligliptin verses Metformin, Teneligliptin is reducing the FBS and PPBS at the same time it shows less side effects, better efficacy when compared to the Metformin.